SUTRO BIOPHARMA, INC. SEC filings

Filings

Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.

1. ROUTINE4SUTRO BIOPHARMA, INC.STROSep 22

   Hans-Peter Gerber, insider filing for STRO

   Hans-Peter Gerber, reporting

2. ROUTINESCHEDULE 13G/ASUTRO BIOPHARMA, INC.STROAug 14

   Ownership stake disclosure by PERCEPTIVE ADVISORS LLC (amended)

   PERCEPTIVE ADVISORS LLC, filed by

3. ROUTINESCHEDULE 13G/ASUTRO BIOPHARMA, INC.STROAug 14

   Ownership stake disclosure by Point72 Asset Management, L.P. (amended)

   Point72 Asset Management, L.P., filed by

4. ROUTINE8-KSUTRO BIOPHARMA, INC.STROAug 14

   Current report

5. NOTABLE10-QSUTRO BIOPHARMA, INC.STROAug 14

   Quarterly report

6. ROUTINESCHEDULE 13GSUTRO BIOPHARMA, INC.STROJul 30

   Ownership stake disclosure by BlackRock, Inc.

   BlackRock, Inc., filed by

7. ROUTINE4SUTRO BIOPHARMA, INC.STROJun 9

   8 insider filings

   Jon Marc Wigginton, insider filing for STRO

   Show all 8

   • 4Insider filing for STROJun 9
   • 4Insider filing for STROJun 9
   • 4Insider filing for STROJun 9
   • 4Insider filing for STROJun 9
   • 4Insider filing for STROJun 9
   • 4Insider filing for STROJun 9
   • 4Insider filing for STROJun 9
   • 4Insider filing for STROJun 9

   Jon Marc Wigginton, reporting

8. ROUTINE8-KSUTRO BIOPHARMA, INC.STROJun 8

   Current report

9. ROUTINE4SUTRO BIOPHARMA, INC.STROJun 2

   Gregory K. Chow, insider filing for STRO

   Gregory K. Chow, reporting

10. ROUTINESCHEDULE 13GSUTRO BIOPHARMA, INC.STROMay 15

    2 13G filings

    Ownership stake disclosure by Samsara BioCapital, L.P.

    Show all 2

    • SCHEDULE 13GOwnership stake disclosureMay 15
    • SCHEDULE 13G/AOwnership stake disclosure (amended)May 15

    Samsara BioCapital, L.P., filed by

11. NOTABLE10-QSUTRO BIOPHARMA, INC.STROMay 14

    Quarterly report

12. ROUTINE8-KSUTRO BIOPHARMA, INC.STROMay 14

    Current report

13. ROUTINESCHEDULE 13G/ASUTRO BIOPHARMA, INC.STROMay 14

    Ownership stake disclosure by Affinity Asset Advisors, LLC (amended)

    Affinity Asset Advisors, LLC, filed by

14. ROUTINESCHEDULE 13GSUTRO BIOPHARMA, INC.STROMay 1

    Ownership stake disclosure by Point72 Asset Management, L.P.

    Point72 Asset Management, L.P., filed by

15. ROUTINEARSSUTRO BIOPHARMA, INC.STROApr 22

    Annual report to shareholders

16. ROUTINEDEFA14ASUTRO BIOPHARMA, INC.STROApr 22

    Additional proxy materials

17. ROUTINEDEF 14ASUTRO BIOPHARMA, INC.STROApr 22

    Proxy statement

18. ROUTINESCHEDULE 13G/ASUTRO BIOPHARMA, INC.STROApr 21

    Ownership stake disclosure by MILLENNIUM MANAGEMENT LLC (amended)

    MILLENNIUM MANAGEMENT LLC, filed by

19. ROUTINESCHEDULE 13GSUTRO BIOPHARMA, INC.STROApr 21

    Ownership stake disclosure by PERCEPTIVE ADVISORS LLC

    PERCEPTIVE ADVISORS LLC, filed by

20. ROUTINEEFFECTSUTRO BIOPHARMA, INC.STROApr 2

    Registration declared effective

21. ROUTINE424B3SUTRO BIOPHARMA, INC.STROApr 1

    Securities offering

22. ROUTINES-3SUTRO BIOPHARMA, INC.STROMar 23

    Securities offering

23. ROUTINES-8SUTRO BIOPHARMA, INC.STROMar 23

    Employee stock plan registration

24. NOTABLE10-KSUTRO BIOPHARMA, INC.STROMar 23

    Annual report

25. ROUTINE8-KSUTRO BIOPHARMA, INC.STROMar 23

    Current report

26. ROUTINE4SUTRO BIOPHARMA, INC.STROMar 6

    2 insider filings

    David Pauling, insider filing for STRO

    Show all 2

    • 4Insider filing for STROMar 6
    • 4Insider filing for STROMar 6

    David Pauling, reporting

27. ROUTINE4SUTRO BIOPHARMA, INC.STROMar 3

    4 insider filings

    David Pauling, insider filing for STRO

    Show all 4

    • 4Insider filing for STROMar 3
    • 4Insider filing for STROMar 3
    • 4Insider filing for STROMar 3
    • 4Insider filing for STROMar 3

    David Pauling, reporting

28. ROUTINESCHEDULE 13GSUTRO BIOPHARMA, INC.STROFeb 18

    Ownership stake disclosure by BIOTECHNOLOGY VALUE FUND L P

    BIOTECHNOLOGY VALUE FUND L P, filed by

29. ROUTINESCHEDULE 13G/ASUTRO BIOPHARMA, INC.STROFeb 13

    2 13G filings

    Ownership stake disclosure by SUVRETTA CAPITAL MANAGEMENT, LLC (amended)

    Show all 2

    • SCHEDULE 13G/AOwnership stake disclosure (amended)Feb 13
    • SCHEDULE 13G/AOwnership stake disclosure (amended)Feb 13

    SUVRETTA CAPITAL MANAGEMENT, LLC, filed by

30. ROUTINE8-KSUTRO BIOPHARMA, INC.STROFeb 10

    Current report

31. ROUTINE424B5SUTRO BIOPHARMA, INC.STROFeb 10

    Securities offering

32. ROUTINESCHEDULE 13G/ASUTRO BIOPHARMA, INC.STROJan 29

    Ownership stake disclosure by Affinity Asset Advisors, LLC (amended)

    Affinity Asset Advisors, LLC, filed by

33. ROUTINE144SUTRO BIOPHARMA, INC.STROJan 20

    Barbara Leyman, planned sale of STRO shares

    Barbara Leyman, reporting

34. ROUTINE4SUTRO BIOPHARMA, INC.STRODec 29, 2025

    4 insider filings

    Jon Marc Wigginton, insider filing for STRO

    Show all 4

    • 4Insider filing for STRODec 29, 2025
    • 4Insider filing for STRODec 29, 2025
    • 4Insider filing for STRODec 29, 2025
    • 4Insider filing for STRODec 29, 2025

    Jon Marc Wigginton, reporting

Older filings on EDGAR